FIELD: experimental medicine.
SUBSTANCE: invention relates to experimental medicine and can be used for photodynamic therapy of grafted Ehrlich solid carcinoma in mice. To do this, the photosensitizer Heliochlorin is administered intravenously at a dose of 5 mg/kg. Then the tumor is irradiated with laser radiation E=150 J/cm2 with a wavelength of 662 nm, power density Ps=0.48 W/cm2, drug-light interval is 45 minutes.
EFFECT: invention provides the maximum antitumor effect in this category of laboratory animals on the 90th day after the photodynamic therapy.
1 cl, 3 tbl
| Title | Year | Author | Number | 
|---|---|---|---|
| METHOD FOR PHOTODYNAMIC THERAPY OF LEFT TUMORS OF MICE EHRLICH CARCINOMA WITH CHLORINE SERIES PHOTO-SENSITIZER | 2022 | 
 | RU2788766C2 | 
| METHOD FOR PHOTODYNAMIC THERAPY OF RAT SURFACE SOLID CONNECTIVE TISSUE SARCOMA M-1 | 2021 | 
 | RU2776449C1 | 
| METHOD OF PHOTODYNAMIC THERAPY OF TRANSPLANTED ECTODERMAL TUMOR OF MELANOMA B16 OF MICE | 2020 | 
 | RU2724867C2 | 
| METHOD OF PHOTODYNAMIC THERAPY OF GROWTH SURFACE SOLID CONNECTIVE-TISSUE SARCOMA OF M-1 RATS | 2019 | 
 | RU2704202C1 | 
| METHOD FOR TREATMENT OF RAT M-1 TRANSFERABLE CONNECTIVE TISSUE SARCOMA UNDER COMBINED IMPACT OF PHOTODYNAMIC THERAPY AND RADIATION THERAPY | 2021 | 
 | RU2767272C2 | 
| METHOD OF COMBINED THERAPY FOR CONNECTIVE TISSUE SARCOMA M-1 IN RATS USING A CONJUGATE OF DIPROPOXYBACTERIOPURPURIN WITH DOXORUBICIN | 2023 | 
 | RU2808909C1 | 
| METHOD FOR TREATMENT OF TRANSLABLE CONNECTIVE TISSUE SARCOMA M-1 IN RATS WITH COMBINED IMPACT OF PHOTODYNAMIC THERAPY AND RADIOTHERAPY | 2021 | 
 | RU2763663C2 | 
| METHOD OF PHOTODYNAMIC THERAPY OF INOCULATED TUMOUR OF B-16 MELANOMA OF MICE WITH CHLORINE PHOTOSENSITIZER WITH PSMA-LIGAND | 2020 | 
 | RU2739193C1 | 
| METHOD FOR ASSESSING ANTITUMOUR EFFECTIVENESS OF PHOTODYNAMIC THERAPY | 2020 | 
 | RU2738301C2 | 
| METHOD OF LOW-INTENSITY LASER RADIATION DURING PHOTODYNAMIC THERAPY WITH A PHOTOSENSITIZER FOTORAN E6 OF A GRAFTED CONNECTIVE-TISSUE SARCOMA TUMOR OF M-1 RATS, POSITIVE IN A MUTANT P53 GENE | 2020 | 
 | RU2736261C2 | 
Authors
Dates
2022-06-21—Published
2021-10-30—Filed